Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 601

1.

No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.

Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, Surachno JS, Mallat MJ, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S.

J Am Soc Nephrol. 2006 Jan;17(1):305-12. Epub 2005 Nov 23. Erratum in: J Am Soc Nephrol. 2006 Apr;17(4):1201. van Groningen, Marian CR [corrected to Roos-van Groningen, Marian C].

PMID:
16306168
[PubMed - indexed for MEDLINE]
Free Article
2.

Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.

Scholten EM, Rowshani AT, Cremers S, Bemelman FJ, Eikmans M, van Kan E, Mallat MJ, Florquin S, Surachno J, ten Berge IJ, Bajema IM, de Fijter JW.

J Am Soc Nephrol. 2006 Sep;17(9):2622-32. Epub 2006 Aug 9.

PMID:
16899517
[PubMed - indexed for MEDLINE]
Free Article
3.

Molecular and structural consequences of early renal allograft injury.

Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA.

Kidney Int. 2002 Feb;61(2):686-96.

PMID:
11849412
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.

Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M; European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.

Nephrol Dial Transplant. 2005 May;20(5):968-73. Epub 2005 Mar 1.

PMID:
15741208
[PubMed - indexed for MEDLINE]
Free Article
5.

Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.

Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.

Transplantation. 1997 Mar 27;63(6):845-8.

PMID:
9089224
[PubMed - indexed for MEDLINE]
6.

Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis.

Murphy GJ, Waller JR, Sandford RS, Furness PN, Nicholson ML.

Br J Surg. 2003 Jun;90(6):680-6.

PMID:
12808614
[PubMed - indexed for MEDLINE]
7.

Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation.

Jurewicz WA.

Nephrol Dial Transplant. 2003 May;18 Suppl 1:i7-11.

PMID:
12738757
[PubMed - indexed for MEDLINE]
Free Article
9.

Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.

Cheung CY, Chan HW, Liu YL, Chau KF, Li CS.

Nephrology (Carlton). 2009 Dec;14(8):758-63. doi: 10.1111/j.1440-1797.2009.01155.x.

PMID:
20025685
[PubMed - indexed for MEDLINE]
10.

Calcineurin inhibitors in pediatric renal transplant recipients.

Filler G.

Paediatr Drugs. 2007;9(3):165-74. Review.

PMID:
17523697
[PubMed - indexed for MEDLINE]
11.

Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.

Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF; Sirolimus High-Risk Study Group.

Transplantation. 2008 Nov 15;86(9):1187-95. doi: 10.1097/TP.0b013e318187bab0.

PMID:
19005398
[PubMed - indexed for MEDLINE]
12.

Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.

Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.

Transplantation. 2009 Aug 15;88(3):421-8. doi: 10.1097/TP.0b013e3181af1df6.

PMID:
19667948
[PubMed - indexed for MEDLINE]
13.

Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.

Aoun B, Decramer S, Vitkevic R, Wannous H, Bandin F, Azema C, Callard P, Brocheriou I, Ulinski T.

Pediatr Nephrol. 2013 Mar;28(3):493-8. doi: 10.1007/s00467-012-2330-6. Epub 2012 Oct 31.

PMID:
23111894
[PubMed - indexed for MEDLINE]
14.

Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.

Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.

Pediatr Transplant. 1999 Feb;3(1):22-6.

PMID:
10359027
[PubMed - indexed for MEDLINE]
15.

Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.

Gotti E, Perico N, Perna A, Gaspari F, Cattaneo D, Caruso R, Ferrari S, Stucchi N, Marchetti G, Abbate M, Remuzzi G.

J Am Soc Nephrol. 2003 Mar;14(3):755-66.

PMID:
12595513
[PubMed - indexed for MEDLINE]
Free Article
16.

Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies.

Roos-van Groningen MC, Scholten EM, Lelieveld PM, Rowshani AT, Baelde HJ, Bajema IM, Florquin S, Bemelman FJ, de Heer E, de Fijter JW, Bruijn JA, Eikmans M.

J Am Soc Nephrol. 2006 Mar;17(3):881-8. Epub 2006 Feb 8.

PMID:
16467444
[PubMed - indexed for MEDLINE]
Free Article
17.

The utility of 6-month protocol renal biopsy under modern immunosuppression.

Yango A, Gohh R, Wang LJ, Morrissey P, Shih M, Lowery K, Charpentier K, Gautam A, Mendonca C, Kumar S, Dworkin L, Monaco A.

Clin Nephrol. 2008 Dec;70(6):490-5.

PMID:
19049705
[PubMed - indexed for MEDLINE]
18.

Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.

Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M.

Transplant Proc. 2008 Dec;40(10):3455-9. doi: 10.1016/j.transproceed.2008.06.089.

PMID:
19100412
[PubMed - indexed for MEDLINE]
19.

Calcineurin inhibitors in renal transplantation: what is the best option?

Tanabe K.

Drugs. 2003;63(15):1535-48. Review. Erratum in: Drugs. 2003;63(20):2234.

PMID:
12887261
[PubMed - indexed for MEDLINE]
20.

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.

Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF; Sirolimus CONVERT Trial Study Group.

Transplantation. 2009 Jan 27;87(2):233-42. doi: 10.1097/TP.0b013e3181927a41.

PMID:
19155978
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk